ABCG2 and atrial fibrillation: Finally, in 2020, Gulilat’s study of 358 Caucasian patients with atrial fibrillation demonstrated the relationship between the ABCG2 421C > A variant (resulting in impaired transporter function) and higher peak and trough blood levels of apixaban [27].